Based on these results, new approaches for addiction therapies have emerged and more may come. For example, pharmacological activation of GIRK channels by administration of the GABAB receptor agonist baclofen reverses behavioral sensitization to morphine in rats159 and clinical Phase 2 & 3 trials are underway examining the effect of baclofen for treating ethanol and cocaine addiction.
